ImageneBio, Inc.IMA
Price (close)
$4.66
Market cap
$75.3M
P/E
—
Revenue (TTM)
$800,000
Net income
-$52.5M
Dividend yield
—
1-year total return
-40.1%
Net margin
—
Revenue growth
—
Debt / equity
0.00x
What ImageneBio, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $9.2M | $31.0M | $15.6M | $9.2M | $3.5M | $800,000 |
| Net income | -$44.3M | -$34.1M | -$68.8M | -$68.2M | -$36.6M | -$45.3M |
| Free cash flow | -$38.6M | -$62.0M | -$75.5M | -$80.2M | — | — |
More on IMA.
- ImageneBio, Inc. summary
- ImageneBio, Inc. financial statements
- ImageneBio, Inc. key metrics
- ImageneBio, Inc. health scores and style box
- ImageneBio, Inc. earnings
- ImageneBio, Inc. dividends
- ImageneBio, Inc. valuation
- ImageneBio, Inc. ownership and insiders
- ImageneBio, Inc. peers
Figures from ImageneBio, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.